Cancer‐associated VTE: caution urged for DOACs in haematological malignancies

Direct oral anticoagulants (DOACs) have changed the management of venous thromboembolism (VTE). In recent years their use has extended to the realm of cancer-associated VTE (CAT), but experts warn that a paucity of trial data in that setting should breed caution in the care of patients with haematological malignancies. “Given the escalated risk of VTE ...

Already a member?

Login to keep reading.

© 2021 the limbic